Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis
NCT00837551
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatitis, Atopic
Interventions
DRUG:
WBI-1001
Sponsor
Welichem Biotech Inc.